Search results for: OHE Consulting
Filter search results
Virtual ISPOR European 2020
10 November 2020
The Virtual ISPOR Europe 2020 will be commencing next week. A number of OHE researchers will be in attendance to present their research. With the theme Improving Health: Establishing Incentives…
Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains
10 March 2021
…well-known issues, and offers a glimpse into the results of a new OHE analysis of approaches to measure efficiency in primary care and recommendations for future research. “The pursuit of…
Medical Manpower
7 January 1966
…disease, consulting a random physician, had a better than fifty-fifty chance of benefiting from the encounter’. Medical progress since then, and especially in the last two decades, has been more…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…are poorly understood, particularly in relation to the new General Data Protection Regulation (GDPR). In this consulting report, sponsored by the European Federation of Pharmaceutical Industries and Associations (EFPIA), we…
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
1 November 2021
…care for patients, the NHS, and wider society, OHE, working on behalf of Novartis, developed an economic model that considers different aspects of transplant care. This model included information on…
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…to ensure that future tumour-agnostic therapies are assessed consistently. Funding: This consulting report was commissioned and funded by F. Hoffmann-La Roche Ltd. Medical writing support for the development of this…
Jon Sussex
28 November 2023
…Centre for Health Economics. Before joining the OHE in 1997, Jon was a management consultant at Deloitte & Touche Consulting where he specialised in health care and regulatory economics. Prior…
Chris Skedgel
15 July 2019
Dr Chris Skedgel has over 25 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…the session and speakers: Dr Amanda Cole, Senior Principal Economist at OHE Josie Godfrey, Director at JG Zebra Consulting Dr Ruth Kim, Value & Evidence Team Leader, Rare Disease and…